Complete amino acid sequence of equine miniplasminogen.

The researchers determined the complete amino acid sequence of equine miniplasminogen and compared it with other species. They found common structural and functional domains and hint that particular positions may be significant in the interaction with streptokinase.

Research Methodology

• The researchers started by determining the complete amino acid sequence of equine miniplasminogen, a member of a class of proteins that aids in breaking down blood clots.
• To achieve this, the team used cleavage fragments, which were gotten by performing cuts or breaks in the protein using 2-(2-nitrophenylsulfenyl)-3-methyl-3′-bromoindolenine, cyanogen bromide or clostripain. These are specialized chemicals used to break down proteins into manageable fragments that researchers can then analyze.
• These fragments were then aligned, meaning their sequences were matched and compared to each other to form a complete sequence. This alignment process facilitated the detection of overlaps, which are areas or sequences appearing more than once.

Comparative Analysis and Findings

• After the successful mapping of the equine miniplasminogen, it was compared sequence-wise to those of other species, specifically bovine (cattle) and canine (dog).
• This comparison found a 76% identity with sequence from bovine and 81% with canine. Identity in this case refers to how similar the sequences were, indicating that all three species share similar structural and functional domains.
• Structural and functional domains refer to parts or segments within the protein sequence that have specific roles or functions within the protein. Finding similarities in these domains across species suggests the possibility of similar biological function and evolutionary relationships.

Significance of Specific Positions in the sequence

• The researchers discovered that positions 49 (Arg), 83 (Arg) and 161 (Ser) in the sequence were significant in the interaction of plasminogen with streptokinase.
• Streptokinase is a bacterial enzyme used in medicine to break down blood clots. When it interacts with plasminogen, it activates it to become plasmin, a more powerful clot-breaking substance.
• The indicated positions may influence how well the plasminogen and streptokinase interact and thus, how efficient the clot-breaking process is.